UNSPSC 51433103: Angiotensinamide

This classification denotes a therapeutic hormone with the molecular formula C49H70N14O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7WAL1X78KV, chemically known as l-phenylalanine, n-(1-(n-(n-(n-(n-(n2-l-asparaginyl-l-arginyl)-l-valyl)-l-tyrosyl)-l-valyl)-l-histidyl)-l-prolyl)- but generally known as angiotensin amide, which bears US NIH Compound Identifier 5890. European Medicines Agency schedules Angiotensinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05511MIG.

UNSPSC 51433103 Angiotensinamide is a Commodity code representing pharmaceutical active ingredients and finished medications used in emergency medical services. State and local governments acquire these products primarily through their fire rescue and emergency medical services divisions to stock advanced life support treatment protocols. The City of Tampa's recent bid for Advanced Life Support Medications (IFB 26P00188, due April 8, 2026) illustrates the actual scope of procurement under this code: while the code nominally names a single active ingredient, municipalities soliciting under it typically bundle multiple emergency medications—in Tampa's case, labetalol, epinephrine, adenosine, and diltiazem—acquired as a single lot for immediate operational use. Fire rescue and EMS agencies are the primary end users; procurement is handled through municipal purchasing departments using IFB mechanics with firm fixed pricing, strict expiration-date management (nine months minimum shelf life), and rapid delivery cycles (ten calendar days). The Tampa solicitation carries a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount capped at $10,000, and requires OSHA Safety Data Sheets and WCAG 2.2 accessibility documentation alongside clinical specifications.

The Tampa Fire Rescue opportunity represents the only recent state or local activity visible under this code. That single IFB, valued at $40,000, was posted in Hillsborough County, Florida in April 2026 with a one-year contract term and renewal options. The geographic concentration reflects the episodic nature of emergency-medication procurement—municipalities buy these products on an as-needed basis rather than through standing open-market solicitations. The Tampa example is representative of the purchasing pattern: direct municipal IFBs with short response windows, firm unit pricing, local delivery logistics, and set-aside eligibility for small or local vendors. Business development activity under this code is driven by municipal fire-rescue procurement cycles and the shelf-life turnover of emergency medications, both of which are jurisdictionally fragmented and difficult to forecast at scale.